Dublin, Feb. 27, 2019 (GLOBE NEWSWIRE) -- The "Cholera Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cholera" report has been added to ResearchAndMarkets.com's offering.

Cholera Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cholera Infection pipeline products.

Report Description:

The Cholera Infection pipeline guide presents complete overview of drugs currently being developed for Cholera Infection. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Cholera Infection pipeline candidate.
Research and Development progress along with latest news related to each of the Cholera Infection pipeline candidates is included.

Major companies participating in therapeutic development of Cholera Infection are included in this pipeline report. Company wise pre-clinical and clinical products along with details of drug originator, co-developers/ licensors are provided.

Amid strong interest for cure of Cholera Infection from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Cholera Infection clinical and pre-clinical products.

The report assists in identifying potential upcoming companies and drugs in Cholera Infection pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Scope of Cholera Infection pipeline report includes:

• Panorama of Cholera Infection pipeline markets including statistics on therapeutic drugs and companies involved
• Cholera Infection Pipeline candidates across various development phases including both pre-clinical, discovery and clinical stages are covered
• Cholera Infection pipeline candidates across various Mechanism of Actions' are also presented in the study
• Overview of companies participating in Cholera Infection pipeline with short introduction to their businesses and pipeline projects
• For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co-developer and licensee are provided.
• Research and Development progress and trial details, results wherever available, are also included in the pipeline study
• The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Cholera Infection pipeline therapeutics

Reasons to Buy:

• Get clear understanding of the entire Cholera Infection pipeline, with details on active projects
• Get in detail information of each product with updated information on each project along with key milestones
• Know the list of companies participating in global Cholera Infection pipeline along with progress of each of the company's products and information on associations/collaborations/licensing data
• Get trial information for each pipeline product under development
• Understand the pipeline structure in terms of mechanism of Action, phase and company

Key Topics Covered:

I. Key Findings

1. Companies Investing in Cholera Infection Pipeline include
Number of Companies with Cholera Infection projects in pre-clinical Development
Number of Companies with Cholera Infection projects in Clinical Development
Cholera Infection Pipeline Companies based in Americas
Cholera Infection Pipeline Companies based in Europe
Cholera Infection Pipeline Companies based in Asia Pacific
Cholera Infection Pipeline Companies based in Rest of the World

2. Pipeline Candidates include
Cholera Infection Pipeline Agents in pre- clinical/ Discovery stage of Development
Cholera Infection Pipeline Agents in Clinical Development stage
Cholera Infection Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs-
Small molecules among the Cholera Infection Pipeline agents

II. Insights into Cholera Infection Pipeline -

1. Disease Overview
Introduction to Cholera Infection
Symptoms and Causes of Cholera Infection
Treatment or Prevention Options for Cholera Infection
Other Details
2. Phase wise Pipeline Compounds
Cholera Infection Pipeline- Pre- Clinical/ Discovery stage Drugs
Cholera Infection Pipeline- Phase 1 stage Drugs
Cholera Infection Pipeline- Phase 2 stage Drugs
Cholera Infection Pipeline- Phase 3 stage Drugs
Cholera Infection Pipeline- Pre-Registration stage Drugs
3. Company wise Cholera Infection Pipeline Compounds
4. Cholera Infection Pipeline by Mechanism of Action

III. Cholera Infection Pipeline Compound Details

• antimicrobial peptide CAP-18
• MucoRice CTB
• cholera vaccine
• Crofelemer

Drug Details

1. Snapshot
Name of the Therapeutic Agent
Originator
Developing Company
Co-Developer/ License Partner
Orphan Drug / Fast Track/ Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details

IV. Cholera Infection Pipeline Company Briefs

• Akthelia Pharmaceuticals Ltd
• Astellas
• Beijing Minhai Biotechnology Co Ltd
• Napo Pharmaceuticals Inc

V. Latest News and Developments in Global Cholera Infection Pipeline Market

VI. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/ljwqwk/cholera_infection?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs